Partnership Tool for the Team Grants: Intervention Trial for Inflammation in Chronic Conditions – Evidence to Impact

This Partnership Tool is meant to facilitate connections and collaborations between researchers, individuals and decision-makers in relation to the Team Grants: Intervention Trial for Inflammation in Chronic Conditions – Evidence to Impact funding opportunity.

The information was provided on a voluntary basis and in no way confers any advantages in the evaluation and funding of applications. Users of the tool use it at their own discretion and responsibility.

The table will be updated weekly until the full application deadline (March 6, 2024).


Notice

Important: To be included in the Partnership Tool, please complete this short form. Once completed, your information will be added to the table during the next update.

The information is provided in the language in which it was submitted by the respondent.

Contact Information Stakeholder/Participant Type Areas of Interest Available resource(s) Additional Information

Joanne Hader
Tel.: 1-902-200-0112
haderjoanne@gmail.com
Canada

Yoga therapist

Implementation and scale-up of any type of evidence-based interventions on humans that leads to clinical impacts on human health addressing inflammation in multiple chronic conditions;

Aging;
Circulatory and respiratory health;
Musculoskeletal health and arthritis;
Alternatives to pharmacologic interventions

In-kind: I would be available to develop the intervention for the proposal and contribute 50% of my fee for delivering the intervention.

 

Mr. David Alfred McDonald-Chiasson
davidchiasson1400@gmail.com
7806761400

Independent researcher

Early Career Researcher

Person with lived or living experience (client, patient, family, caregiver, etc.)

Knowledge User (e.g., policy-maker, health practitioner, industry, government, etc.)

Other- Refundable concerns

Repurposing existing solutions: generating evidence that an intervention proven directly or indirectly effective for one chronic inflammatory condition is also effective in the treatment of one or more other inflammatory chronic conditions

Optimizing existing solutions: optimize response for population subgroups that have been underrepresented in research (e.g., women, LGBTQIA/2S populations, pregnant people) and those across life stages (e.g., children, older adults)

Demonstrating safety, efficacy, and/or effectiveness of validated new targets common to multiple chronic conditions and that bring clinical impacts

Addressing behavioral or socio-structural changes for inflammation prevention or management in multiple chronic conditions leading to clinical impacts on human health

Implementation and scale-up of any type of evidence-based interventions on humans that leads to clinical impacts on human health addressing inflammation in multiple chronic conditions

HIV/AIDS and/or other sexually transmitted and blood-borne infections that comprise elements of chronic inflammation

General areas of interest: Infection and immunity; Aging; Circulatory and respiratory health; Gender and health; Musculoskeletal health and arthritis; Nutrition, metabolism and diabetes; HIV/AIDS and sexually transmitted blood-borne infections; Knowledge mobilization; Patient engagement; Drug development; Decision-making, regulatory and ethics; Other - Trades

In-kind: Statistics Services

Date modified: